Core Insights - The article discusses the best 4K TVs available, emphasizing that resolution alone does not guarantee picture quality, with factors like contrast, color accuracy, and brightness being crucial for performance [1][2]. Group 1: Best Overall Picks - The Samsung S90F OLED is highlighted as the best overall 4K TV due to its stunning contrast, vibrant colors, and deep black levels [2][10]. - The TCL QM6K is recommended as the best budget option, offering excellent picture quality at a lower price point, although it does not achieve the brightness of higher-end models [2][24]. Group 2: Specific Recommendations - The LG C5 is noted as the best midrange OLED, providing high contrast and deep black levels, with a peak brightness of around 1,175 nits [33][38]. - The Samsung S95F is recognized for its anti-glare display, featuring a peak brightness of 2,170 nits, making it ideal for bright rooms [45][50]. Group 3: Smart TV Systems - The Roku Pro Series is praised for its simple and reliable interface, rechargeable voice remote, and hassle-free setup, making it a strong choice for users seeking an easy smart TV experience [56][60]. - The TCL QM7K is highlighted as the best mid-tier QLED, featuring a Mini LED backlight with local dimming and a peak brightness of about 1,800 nits, enhancing HDR performance [70][76]. Group 4: Performance Metrics - The Samsung S90F measures a peak brightness of 1,460 nits, which is about 200 nits higher than its predecessor, the S90D [12][10]. - The TCL QM6K achieves a peak brightness of 557 nits on a 10% HDR test pattern, which is competitive for its price range [26][24].

Market Overview - The bond market has been stable, but recent breakouts have affected equity markets, with investors adjusting to the potential appointment of Kevin Walsh as Fed chair, who is perceived as an inflation hawk but has made dovish comments recently [2][3] - The Reserve Bank of Australia raised interest rates, leading to a strengthening of the Australian dollar, indicating global market dynamics at play [4] - Yield differentials across global markets are being monitored, especially with Japan's upcoming election potentially adding volatility [5] Equity Market Performance - The "Magnificent 7" tech stocks index declined by approximately 1.6%, while the NASDAQ 100 fell by about 1.55%, despite 55% of S&P 500 components showing gains [7] - The gold market experienced a significant $300 price movement, suggesting volatility influenced by currency fluctuations [8] Upcoming Economic Data - The ADP report will provide insights into the job market, as the government shutdown has delayed the usual payroll data collection [10] - The ISM non-manufacturing PMI is expected to carry significant weight, especially since the economy is service-led, and previous PMI data showed improvement [11] Earnings Reports - A busy earnings calendar includes major companies such as Uber, Eli Lilly, Alphabet, ARM, Qualcomm, and Snap, which are anticipated to dominate headlines [13][14] - AMD's performance will be closely watched to see if it stabilizes and potentially reignites interest in tech stocks [12][14]

Samsung Reveals Exclusive Android Upgrade For Galaxy S26 UltraJust ahead of Samsung’s all new Galaxy S26 release, including the Galaxy S26 Ultra, there’s another reason to upgrade. Samsung is raising the bar with new hardware and software, including an Android exclusive from Google. https://t.co/DebrHH1VWs (Photo: NurPhoto via Getty Images) ...

SanDisk (SNDK) stock just got one of the most aggressive votes of confidence on Wall Street. Bernstein SocGen Group analyst Mark C. Newman just dropped a jaw-dropping new price target of $1,000 on the memory chip players' stock while keeping an outperform rating. The new target represents a 72.4% increase from the prior $580 target and roughly 50% upside from the current price of $665. For perspective, that’s the highest price target on the Street, with consensus average price targets pointing to modest ...

Core Insights - Micron Technology's stock surged 45.4% in January 2026, driven by rising memory prices due to high demand from AI companies [1] - The memory shortage is intensifying, with Micron's high bandwidth memory (HBM) already sold out for 2026 before the year began [2] - Analysts expect Micron's annual earnings to quadruple next year, indicating significant growth potential [3] Company Strategy - Micron is focusing on HBM production by building new manufacturing facilities and adjusting its product mix, including discontinuing its consumer brand Crucial [4] - The company's in-house chip-making facilities provide a competitive advantage, allowing it to meet AI accelerator demand without relying on third-party manufacturers [5] Financial Performance - As of February 3, Micron's stock has increased by 80% in two months and 303% in six months, yet it remains undervalued with a forward P/E ratio of 9.7 and a PEG ratio of 0.13 [6]

Core Insights - Corning Incorporated (GLW) reported strong fourth-quarter 2025 results, with adjusted earnings and revenues surpassing Zacks Consensus Estimates, driven by a resilient business model and robust portfolio [1][9] Group 1: Optical Communications and Specialty Materials - The Optical Communications segment is the primary growth driver, with a 24% year-over-year increase in Q4 sales to $1.7 billion and a full-year surge of 35% to $6.3 billion, fueled by AI-enabled data center infrastructure [3][2] - A significant multiyear agreement with Meta Platforms, valued at $6 billion, will enhance Corning's optical fiber and connectivity products for high-speed AI data centers, bolstering domestic supply chains and reducing geopolitical risks [2] - Specialty Materials segment sales grew 4% year-over-year to $544 million in Q4, with net income rising 22%, driven by strong demand for Gorilla Glass and collaborations with major clients like Apple and Samsung [4] Group 2: Challenges and Market Dynamics - Corning's growth in Optical Communications is heavily reliant on hyperscaler spending on AI infrastructure, making it vulnerable to macroeconomic changes [5] - The Display segment experienced a 2% year-over-year decline in net sales, and the Automotive segment faces headwinds due to weakness in light and heavy-duty markets, particularly in Europe and North America [5][7] - Limited end market diversification within the Display and Optical segments narrows growth potential, as these segments account for over half of total revenues [6] Group 3: Financial Performance and Valuation - Corning's stock has gained 112%, outperforming the S&P 500 and the Zacks Computer & Technology sector, although it has underperformed compared to competitors like Ciena [10][11] - Earnings estimates for 2025 and 2026 have increased over the past 60 days, indicating growing investor confidence [12] - Currently, Corning's shares trade at a price/earnings ratio of 35.34, lower than the industry average of 36.74, suggesting a valuation discount [13]

Core Insights - The article emphasizes the importance of international equity exposure for investors, highlighting that significant market value exists outside the U.S. [2] - The Schwab International Equity ETF (SCHF) offers a low-cost solution to address home bias in investing, providing access to developed market equities [2][3] Group 1: Fund Overview - SCHF manages approximately $55.4 billion in assets and provides access to around 1,300 established companies across Europe, Japan, Canada, and Australia [3] - The fund's expense ratio is notably low at 0.03% annually, allowing investors to retain more of their returns while benefiting from a 2.35% dividend yield [3] Group 2: Performance Comparison - Over the past decade, SCHF returned 167%, while the SPY delivered 264%, resulting in a 97 percentage point performance gap primarily due to U.S. tech dominance and dollar strength [4][8] - Recent performance indicates a positive trend, with SCHF gaining 35% over the past year, significantly higher than its five-year annualized return of 11% [6] Group 3: Competitive Advantage - SCHF's cost structure is a key differentiator, with its 0.03% expense ratio significantly lower than competitors like EFA at 0.32% and comparable to VEA at 0.05% [7] - The fee difference compounds over time, favoring cost-conscious investors and enhancing long-term returns [7]

It's Tuesday, the third. Good morning. How you doing.This is what we're talking about. Golden Tech have bounced. Australia has hiked.And Elon Musk has plans to take the trade into orbit on a big session over in Asia, particularly this coming through on the course in South Korea. That trade is back up 3% across the regional benchmark. You're seeing the ripple effects that European futures pointing to gains of 5/10 of a percent after record highs for European stocks yesterday with upside of more than 1% gold ...

Industry Overview - The Zacks Medical - Products industry is facing challenges due to tariffs imposed by the U.S. on trading partners, impacting margins for companies like GE HealthCare, Baxter, and Abbott [1] - Medical device makers are experiencing rising commodity and manufacturing costs post-COVID-19, particularly in consumer-facing areas like Nutrition, leading to price hikes that may constrain volume due to increased price sensitivity among consumers [2] - The industry's profitability is under strain from tariff-related expenses and persistent component shortages, which create inefficiencies and constrain output [7] Trends and Innovations - Industry players are mitigating challenges through product innovation and the adoption of AI and digital services, with the rise of GLP-1 medication acting as a tailwind for certain medical device areas [3] - The market for remote patient monitoring platforms is projected to reach $57 billion by 2030, driving margin expansion and shifting profit pools from hardware to data-driven services [9] - The U.S. market is shifting from inpatient hospital settings to Ambulatory Surgery Centers (ASCs) and home-based monitoring, with the ASC market expected to reach $205 billion by 2030 [10] Company Performance - Boston Scientific (BSX) is positioned for strong growth driven by demand across its diversified product portfolio, with a commitment to over 10% growth over the next three years [29] - ResMed is experiencing strong momentum with 11% top-line growth in Q2 fiscal 2026, driven by rising demand for CPAP therapy and the adoption of GLP-1 drugs [35][36] - Phibro Animal Health Corporation (PAHC) is benefiting from the integration of the Zoetis Medicated Feed Additive portfolio, contributing $80.5 million in sales in Q1 fiscal 2026, and expects favorable net price impacts to improve profitability [42] Financial Outlook - The Zacks Consensus Estimate for BioLife Solutions (BLFS) indicates a 16.4% revenue growth for 2026, with earnings expected to grow by 38.1% [27] - Boston Scientific's revenue for 2026 is estimated at $22.32 billion, projecting an 11.3% growth, with EPS expected to improve by 13.5% [32] - ResMed's revenue for fiscal 2026 is pegged at $5.58 billion, indicating an 8.5% growth, with EPS expected to rise by 15% [39] - PAHC's revenue for fiscal 2026 is estimated at $1.47 billion, projecting a 13.1% growth, with EPS expected to improve by 32.1% [46]

No one mentioned Micron in Apple's latest earnings call. They didn't have to.When Apple (AAPL +4.12%) provides quarterly updates, it only makes sense that everyone focuses on how the latest news impacts Apple itself. Sometimes, though, the information provided by Apple's management team has ramifications for other companies.That was the case with the iPhone maker's fiscal year 2026 first-quarter earnings call last week. Apple CEO Tim Cook just gave great news for Micron Technology (MU +5.42%) investors. App ...